Navigation Links
Mental Health Watchdog Launches Psychiatric Drug Side Effects Database—Search All Drug Regulatory Agency Warnings, Studies & Adverse Reactions Reports
Date:8/14/2013

Los Angeles, California (PRWEB) August 14, 2013

With one in five Americans currently taking prescribed psychiatric drugs (according to Medco Health Solutions), the mental health watchdog, Citizens Commission on Human Rights (CCHR), is concerned the public are not being accurately informed of the documented risks. Taking its commitment to inform and protect the public on mental health issues to a new level, CCHR has launched a comprehensive redesign of its website (http://www.cchrint.org) and enhanced drug database which features 211 psychiatric drug regulatory agency warnings, 223 studies, and over 400,000 adverse reactions reported to the US FDA by doctors, pharmacists, health care providers and consumers.

Wholly aware that trying to sift through the massive amount of data available on the web can be daunting to even the most seasoned researcher, CCHR painstakingly created the definitive guide to documented psychiatric drug side effects, taking the official FDA adverse reaction reports (MedWatch data), international drug regulatory agency warnings and studies, then summarized the often complex information into an easy, user-friendly format for consumers, researchers and policy makers.

For example, the FDA itself does not provide a way for the public to easily utilize the adverse reaction reports contained on their website, and while the data is available for downloading, it requires a programmer to decrypt the complex coding system, comprised of seven text files—over 94,000 pages per year (see side bar image for example of text files.) More than 2,000 hours were spent compiling the data into a user friendly format, which is now available for the general public. Now anyone can easily search side effects reported to the FDA (by doctors, pharmacists, health care providers and consumers) as well as international drug regulatory agency warnings and studies issued on antidepressants, antipsychotics and psycho-stimulants to name a few.

According to the FDA's MedWatch data, between 2004 and 2012, there were more than four hundred thousand adverse reactions from psychiatric drugs reported to the federal drug agency, including drug induced attempted and completed suicides and homicides. While the FDA itself estimates that less than 1% of all serious adverse events are reported directly to it, CCHR states the importance of the Medwatch data is that it represents some of the only post-market surveillance data on psychiatric drugs available. The fact is, the FDA approves psychiatric drugs for public consumption based on short term clinical drug trials (frequently only 6-8 weeks) and does not require drug makers to study the drug’s long term effects once they are out in the consumer market and out of the controlled protocols of drug makers.

In addition to the interactive drug database, CCHR also created web pages summarizing all documented risks of the main classes of psychiatric drugs, such as the following:

Antidepressant drug risks - 99 drug regulatory agency warnings, 119 studies, and 136,239 adverse reactions reported to the FDA. These include:

  • self-harm
  • anxiety
  • withdrawal symptoms
  • death
  • mania or psychosis
  • hallucinations or delusional thinking
  • depression
  • sexual dysfunction
  • homicidal ideation
  • diabetes

Antipsychotic drug risks - 55 drug regulatory warnings, 77 studies, and 118,624 adverse reactions reported to the FDA, including:

  • death/sudden death
  • heart problems
  • withdrawal symptoms
  • convulsions, seizures or tremors
  • diabetes
  • birth defects
  • agitation
  • mania and psychosis
  • sexual dysfunction

ADHD drug risks - 31 drug regulatory warnings, 20 studies, and 17,702 adverse reactions reported to the FDA, including:

  • heart problems
  • mania/psychosis
  • death
  • hallucinations
  • depression
  • violence, hostility or aggression
  • seizures
  • suicide risk/attempts
  • anxiety

Anti-anxiety drug risks - 17 drug regulatory warnings, 18 studies, and 35,230 adverse reactions reported to the FDA. These include:

  • death and sudden death
  • violence
  • homicidal ideation
  • suicide risk/attempts
  • birth defects
  • addiction

There are also summarized pages for specific top-selling, brand-name drugs such as Prozac, Paxil, Zoloft, Celexa, Ripserdal, Seroquel, Ativan, Ritalin, Adderall, Concerta, Provigil, Klonopin, Ambien, Xanax, and many more.

Too often, important scientific studies are lost on the public due to the confusing and complex nature of such reporting. In an effort to make this information available on a more basic level, the interactive psychiatric drug database allows users to customize their searches by class of drug, brand name of drug, age range and/or a particular side effect. The drug database was created by CCHR as a free public service.

View the new website here and the new Psychiatric Drug Side Effects Database here.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10998084.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mental health youth report paves the way for improved access to youth services
2. Unlock The Brain’s Fundamental Nutrition and Necessities with Dr. Bob, “The Drugless Doctor”
3. Inside Edition’s Lisa Guerrero and Entertainment Industries Council “Get Real” About Mental Health
4. Study to investigate mental health care for prisoners
5. Forward Progress TV to Present Segments on the Best Environmental Companies in the U.S.
6. Dr. Carol Francis Talk Radio - Fifth Year Anniversary Show on "Success Tools, Professional Mental Health & Physical Fitness Advice, Social Justice Issues, Soulful Guests"
7. U.S. Environmental Biotechnology Product Market: 2018 Forecasts and Analysis Research Report Now Available at ReportsnReports.com
8. It’s OK2TALK About Mental Health
9. New Waterhog Eco Elite Fashion Carpet Mats from Martinson-Nicholls Are Durable, Attractive and Environmentally Friendly
10. Pure Prodigy's L-Tyrosine Shown in Studies to Improve Mental Alertness Under Stress
11. Triple Anti-Oxidant Liver Formula, a Proactive Approach to Dealing with Environmental Toxins, is Now Available for a Complimentary Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Lake City, UT (PRWEB) , ... April 24, 2017 , ... ... their efforts to encourage sustainability, innovate new strategies to reduce waste, and support renewable ... herbal remedy provider. They look to nature to find solutions for health issues, and ...
(Date:4/24/2017)... CO (PRWEB) , ... April 24, 2017 , ... ... American Educational Research Association’s Outstanding Public Communication of Education Research Award. The award ... public, including education communities. It recognizes a scholar who has demonstrated the capacity ...
(Date:4/24/2017)... ... ... Pink , a national non-profit organization focusing on the prevention and early detection of breast ... proud to announce Katie Thiede as their new Chief Executive Officer. In January, founder Lindsay ... the Board and launched a national search to find a visionary new leader to grow ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the undisputed ... Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than 100 ... in the last 25 years. , Now, due to changes in the broadcast media ...
(Date:4/24/2017)... ... April 24, 2017 , ... The John P. McGovern Museum of Health ... anywhere to track their cognitive health, and share results with their physicians. Members and ... on the museum's website. , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, ... today unveiled a new store design to enhance ... of healthier food, health-focused products and expanded beauty ... to help customers discover new offerings. Together with ... next evolution of the customer experience at CVS ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
Breaking Medicine Technology: